---
title: ClinActis Pte Ltd vs Innovate Research
slug_a: clinactis
slug_b: innovate-research
site: cro
review_signal_gate: closed
canonical_path: /compare/clinactis/innovate-research
---

# ClinActis Pte Ltd vs Innovate Research

Side-by-side profile data from each company listing on this directory.

## ClinActis Pte Ltd

- Profile: [/companies/clinactis](/companies/clinactis)

ClinActis Pte Ltd — Full-service CRO delivering clinical trial services across Asia Pacific, with 50+ years of cumulative experience managing Phase I–IV trials and expertise in oncology, cardiovascular, CNS, and infectious disease indications.

Services: 10. Modalities: 0. Indications: 5. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Neurology
- Cardiovascular
- Infectious Disease
- Respiratory

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Functional Service Provider (FSP)

## Innovate Research

- Profile: [/companies/innovate-research](/companies/innovate-research)

Innovate Research — Indian CRO providing end-to-end clinical trial services (Phase I–IV), regulatory support, medical writing, biostatistics, data management, and biospecimen procurement across pharmaceuticals, biologics, medical devices, and nutraceuticals.

Services: 11. Modalities: 3. Indications: 0. Locations: 5. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Other)
- Vaccine

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)